A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Kelly Faulk](https://som.ucdenver.edu/FIMS/Content/faculty/14055/CU-Doctors-14055.jpg)
Kelly Faulk
Study ID
Protocol Number: 22-1254
More information available at ClinicalTrials.gov: NCT05183035
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers